Cognitive decline is a common problem associated with cancer and its treatments but can be difficult to assess with traditional measures. For example, many patients report cognitive deficits yet their neuropsychological testing indicates they are functioning “normally.” This discrepancy suggests that standard neuropsychological tests may not be adequate for assessing cancer-related cognitive decline. Therefore, in this study, we will examine some new methods for measuring cognitive function in patients with cancer.
We are currently seeking breast, gynecologic, gastrointestinal, prostate, colorectal, testicular, head/neck, hematologic or brain cancer patients and survivors as well as individuals with no cancer history age 21 years or older to help us evaluate our new assessment methods.
This study is funded by the University of Texas at Austin and includes collaborations with Stanford Cancer Center, MD Anderson Cancer Center and Medical College of Wisconsin.
Contact: Please contact us to discuss how you can participate by emailing email@example.com.
- To participate, you must be 21 years or older.
- You must meet one of the following criteria:
- Newly diagnosed patient with breast, gynecologic, gastrointestinal, prostate, colorectal, testicular, head/neck, hematologic or brain cancer who has not yet begun cancer treatment or is early in their treatment course.
- Patient with breast, gynecologic, gastrointestinal, prostate, colorectal, testicular, head/neck, hematologic or brain cancer who has completed cancer treatments at least 6 months ago, is on maintenance therapy, or is later in their treatment course.
- An adult with no history of cancer.
- You must be able to read and speak English.
- You must have a computer with internet access.
If you decide to participate, we will ask you to complete some online assessments just one time. These will include:
- A questionnaire that assesses thinking and writing skills as well as physical and mental health (approximately 20-30 minutes).
- A test that measures measure memory, thinking and attention skills (approximately 10-15 minutes).
- A questionnaire regarding your medical/treatment history (5-10 minutes; for cancer patients and survivors only)
These assessments will be completed online at home. One of our research staff will guide you through the process of completing them via videoconferencing.
There are no in-person study visits involved.
You will receive a $25 gift card for your participation.